More than a quarter of patients with atrial fibrillation who are at low risk of stroke are being ‘inappropriately’ prescribed an oral anticoagulant, a recent audit of UK general practices has claimed.
Researchers ran the computerised GRASP-AF (Guidance on Risk Assessment and Stroke Prevention in Atrial Fibrillation) audit tool on electronic records of 11 general practices.
Of the 7.5% of patients with atrial fibrillation who were considered at low risk of stroke, according to the CHA2DS2-VASc score now endorsed by NICE guidelines for atrial fibrillation, 28%were on oral anticoagulants.
Just half of patients at moderate-high risk of stroke were on the recommended treatment of an oral anticoagulant, while about 40% were on an antiplatelet – which is no longer recommended for stroke prevention.
The researchers concluded: ‘Oral anticoagulant therapy in atrial fibrillation remains suboptimal in the UK general practice settings, with suboptimal treatment of high-risk patients and inappropriate oral anticoagulant use in low-risk patients.
‘Aspirin monotherapy use remained excessive in high-risk patients, despite exposing such patients to an increased risk of stroke.’
The findings were presented at a poster session at the annual European Society of Cardiology congress in Barcelona.
European Society of Cardiology Congress 2014; Abstract P2630
Click here to find out more about our campaign
Please click here to sign our petition now!
Visit Pulse Reference for details on 140 symptoms, including easily searchable symptoms and categories, offering you a free platform to check symptoms and receive potential diagnoses during consultations.
